NEW YORK, NY / ACCESSWIRE / July 27, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Ocugen, Inc. (NASDAQ:OCGN)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/ocugen-inc-loss-submission-form?prid=17992&wire=1
Lead Plaintiff Deadline: August 17, 2021
Class Period: February 2, 2021 - June 10, 2021
Allegations against OCGN include that: (i) the information submitted to the U.S. Food and Drug Administration ("FDA") was insufficient to support an Emergency Use Authorization ("EUA"), (ii) Ocugen would not file an EUA with the FDA, (iii) as a result of the foregoing, the Company's financial statements, as well as Defendants' statements about Ocugen's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
Home Point Capital Inc. (NASDAQ:HMPT)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/home-point-capital-inc-loss-submission-form?prid=17992&wire=1
Lead Plaintiff Deadline: August 20, 2021
This lawsuit is on behalf of all persons and entities other than Defendants that purchased or otherwise acquired Home Point common stock pursuant and/or traceable to the Company's January 29, 2021 initial public offering.
Allegations against HMPT include that: (i) Home Point's aggressive expansion of its broker partners would dramatically increase the Company's expenses; (ii) the mortgage industry was anticipating industry-wide decreased gain-on-sale margins as a result of rising interest rates in 2021 and Home Point would be subject to the same competitive pressures; (iii) accordingly, the Company had overstated its business and financial prospects; and (iv) as a result, the Offering Documents were materially false and/or misleading and failed to state information required to be stated therein.
Piedmont Lithium Inc. (NASDAQ:PLL)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/piedmont-lithium-inc-loss-submission-form?prid=17992&wire=1
Lead Plaintiff Deadline: September 21, 2021
Class Period: March 16, 2018 - July 19, 2021
Allegations against PLL include that: (1) Piedmont has not, and would not, follow its stated steps or timeline to secure all proper and necessary permits; (2) Piedmont failed to inform relevant people and governmental authorities of its actual plans; (3) Piedmont failed to file proper applications with relevant governmental authorities (including state and local authorities); (4) Piedmont and its lithium business does not have "strong local government support"; and (5) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.
To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]
SOURCE: The Law Offices of Vincent Wong